Optimal positive lymph node ratio showing the benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: an exploratory study using the Surveillance, Epidemiology, and End Results data
Shiho Lee, O Kyu Noh
Radiat Oncol J. 2022;40(1):37-44. Published online 2022 Mar 22 DOI: https://doi.org/10.3857/roj.2021.00969
Citations to this article as recorded by 
Predictive Value of Clinicopathological Factors to Guide Post-Operative Radiotherapy in Completely Resected pN2-Stage III Non-Small Cell Lung Cancer
Ju-Chun Chien, Yu-Chang Hu, Yi-Ju Tsai, Yu-Ting Chien, I-Jung Feng, Yow-Ling Shiue
Diagnostics.2023; 13(19): 3095. CrossRef
Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer
Byoung Hyuck Kim, Jae Sik Kim, Hak Jae Kim
Radiation Oncology Journal.2023; 41(3): 144. CrossRef